NASDAQ
Cyclerion Therapeutics, Inc. (CYCN) has a fcf yield of -80.91% as of Monday, August 3, 2026. This represents a 37.92% increase compared to its 12-month average of -130.35%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.